Anna Tsantili-Kakoulidou

发表

Challenges with multi-objective QSAR in drug discovery

George Lambrinidis, Anna Tsantili-Kakoulidou, G. Lambrinidis, 2018, Expert opinion on drug discovery.

The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.

Anna Tsantili-Kakoulidou, Theodosia Vallianatou, Costas Giaginis, 2015, Advances in experimental medicine and biology.

The 18th European Symposium on Quantitative Structure–Activity Relationships

Dimitris K Agrafiotis, Anna Tsantili-Kakoulidou, D. Agrafiotis, 2011, Expert opinion on drug discovery.

QSAR/QSPR Modeling in the Design of Drug Candidates with Balanced Pharmacodynamic and Pharmacokinetic Properties

George Lambrinidis, Anna Tsantili-Kakoulidou, Fotios Tsopelas, 2017 .

The Position of ADME Predictions in Multi-Objective QSAR

Anna Tsantili-Kakoulidou, A. Tsantili-Kakoulidou, 2021 .

Applying quantitative structure-activity relationship (QSAR) methodology for modeling postmortem redistribution of benzodiazepines and tricyclic antidepressants.

Anna Tsantili-Kakoulidou, Stamatios Theocharis, Constantinos Giaginis, 2014, Journal of analytical toxicology.

Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention.

Anna Tsantili-Kakoulidou, Costas Giaginis, A. Tsantili-Kakoulidou, 2008, Journal of pharmaceutical sciences.

The potential of immobilized artificial membrane chromatography to predict human oral absorption.

Anna Tsantili-Kakoulidou, Theodosia Vallianatou, Theodosia Vallianatou, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine

Emmanuel Mikros, Manfred Spraul, Anna Tsantili-Kakoulidou, 2005 .

Structural effects in the lipophilicity of di- and polysubstituted benzenes as measured by reversed-phase high-performance liquid chromatography

Han van de Waterbeemd, Bernard Testa, Anna Tsantili-Kakoulidou, 1987 .

Lipophilicity and biomimetic properties to support drug discovery

Anna Tsantili-Kakoulidou, Constantinos Giaginis, A. Tsantili-Kakoulidou, 2017, Expert opinion on drug discovery.

In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.

George Lambrinidis, Anna Tsantili-Kakoulidou, Theodosia Vallianatou, 2015, Advanced drug delivery reviews.

Multivariate Statistics of Disposition Pharmacokinetic Parameters for Structurally Unrelated Drugs Used in Therapeutics

Panos Macheras, Anna Tsantili-Kakoulidou, Vangelis Karalis, 2002, Pharmaceutical Research.

Current State of the Art in HPLC Methodology for Lipophilicity Assessment of Basic Drugs. A Review

Anna Tsantili-Kakoulidou, Costas Giaginis, A. Tsantili-Kakoulidou, 2007 .

Exploring the consistency of logP estimation for substituted coumarins

Anna Tsantili-Kakoulidou, Demetris Vrakas, Dimitra Hadjipavlou-Litina, 2003 .

A Quantitative Structure-Activity Relationship (QSAR) Study of Alkylpyrazine Odor Modalities

Lemont B. Kier, Anna Tsantili-Kakoulidou, L. Kier, 1992, Pharmaceutical Research.

Simple physicochemical properties related with lipophilicity, polarity, molecular size and ionization status exert significant impact on the transfer of drugs and chemicals into human breast milk

Nikolaos Kavantzas, Anna Tsantili-Kakoulidou, Stamatios Theocharis, 2016, Expert opinion on drug metabolism & toxicology.

Different partitioning behaviour of sulphonyl-containing compounds in reversed-phase high-performance liquid chromatography and octanol-water systems

Bernard Testa, Anna Tsantili-Kakoulidou, Nabil El Tayar, 1988 .

Lipophilicity Studies on Pyrrolyl‐Acetic Acid Derivatives. Experimental Versus Predicted logP Values in Relationship with Aldose Reductase Inhibitory Activity

Ioannis Nicolaou, Anna Tsantili-Kakoulidou, A. Tsantili-Kakoulidou, 2009 .

18th EuroQSAR: Perspectives on QSAR, Molecular Informatics and Drug Design

Dimitris K Agrafiotis, Anna Tsantili-Kakoulidou, 2011, Molecular informatics.